Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:proteinase_inhibitor |
| gptkbp:ATCCode |
gptkb:B02AB01
|
| gptkbp:brand |
gptkb:Trasylol
|
| gptkbp:CASNumber |
gptkb:9087-70-1
|
| gptkbp:discoveredBy |
gptkb:Bayer_AG
|
| gptkbp:hasMolecularFormula |
C284H432N84O79S7
|
| gptkbp:inhibitedBy |
gptkb:kallikrein
gptkb:trypsin chymotrypsin plasmin serine proteases |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:origin |
bovine lung
|
| gptkbp:PubChem_CID |
16129731
|
| gptkbp:reintroducedToMarket |
2012
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
myocardial infarction
stroke anaphylaxis renal dysfunction |
| gptkbp:UNII |
93443-35-7
|
| gptkbp:usedFor |
cardiac surgery
reducing blood loss during surgery |
| gptkbp:withdrawn |
2007
|
| gptkbp:bfsParent |
gptkb:Trasylol
gptkb:antifibrinolytic_drugs gptkb:Chymotrypsin gptkb:trypsin |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
aprotinin
|